Treatment with AdipoRon, a synthetic adiponectin analog, rescues autophagic flux in T2DM hearts post-MI-R by activating the AMPK pathway, as evidenced by increased expression of MAP1LC3, LAMP2, PIK3C3/VPS34, and BECN1. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.